Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length.
Salmonellae, the lipopolysaccharide of which differ in the chemical structure of their O-antigenic side chains, were previously shown to activate C3 at differential rates via the alternative pathway. We wanted to test whether lipopolysaccharide isolated from these strains yields identical results, and also the effect of the polysaccharide chain length, which varies from 0 to 40 or more repeating units in a single strain. Lipopolysaccharide was purified from the above strains, hydrolyzed (0.1 N NaOH, 56 degrees C, 30 min), and used to coat sheep erythrocytes to different densities, and C3 activation in C4-deficient guinea pig serum was measured. C3 activation was proportional to lipopolysaccharide density and time, and the relative rates and extents of activation by this bacteria-free system were the same as for the original bacteria. Activation was reduced 10 to 15% when the serum was preabsorbed with strains either containing or lacking O-antigen side chain, suggesting augmentation by antibody; however, even after multiple absorptions, activation varied with O-antigen structure as expected. This differential activation was not due to differences in the average length of the O-antigenic polysaccharide chains, because the size was similar for all three lipopolysaccharides. Moreover, the extent of activation by lipopolysaccharide that had been fractionated on a column of Sephadex G-200 was independent of the polysaccharide chain length for lengths greater than 3 repeating units. The results prove that C3 activation by lipopolysaccharide via the alternative pathway is sensitive to slight variations in the chemical structure, but not to large variations in length of the O-antigen polysaccharide side chain of lipopolysaccharide.
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D055598:Chemical Phenomena; D002621:Chemistry; D002850:Chromatography, Gel; D003167:Complement Activation; D003170:Complement Pathway, Alternative; D004912:Erythrocytes / Q000276:immunology / Q000378:metabolism; D006168:Guinea Pigs; D008070:Lipopolysaccharides / Q000145:classification / Q000378:metabolism / Q000494:pharmacology*; D019081:O Antigens; D012480:Salmonella Infections / Q000276:immunology*; D012486:Salmonella typhimurium / Q000032:analysis / Q000276:immunology; D012756:Sheep
D000942:Antigens, Bacterial; D008070:Lipopolysaccharides; D019081:O Antigens